Advertisement
Advertisement
U.S. Markets open in 8 hrs 5 mins
Advertisement
Advertisement
Advertisement
Advertisement

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
14.58+0.42 (+2.97%)
At close: 04:00PM EDT
15.00 +0.42 (+2.88%)
After hours: 07:16PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close14.16
Open14.27
Bid0.00 x 3100
Ask0.00 x 4000
Day's Range14.26 - 14.68
52 Week Range13.17 - 17.56
Volume5,295,095
Avg. Volume2,531,112
Market Cap45.419B
Beta (5Y Monthly)1.00
PE Ratio (TTM)11.20
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.80 (5.60%)
Ex-Dividend DateSep 29, 2021
1y Target EstN/A
  • Business Wire

    Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022

    OSAKA, Japan, May 11, 2022--Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2021 (period ended March 31, 2022), driven by the performance of its growth products, new product launches and strength across its key business areas.

  • GlobeNewswire

    CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally

    Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to genetic testing for patients with rare metabolic and rare neurodegenerative diseasesThe global market access and expansion partnership initially established in 2015 aims to provide an efficient and timely diagnosis to patientsDiagnosis remains crucial for patients, leading them towards suitable readily available t

  • Business Wire

    Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two Categories

    OSAKA, Japan & CAMBRIDGE, Mass., April 26, 2022--Takeda (TSE:4502/NYSE:TAK) today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company top honors in the Supply Chain and Pharma 4.0™ categories for the 2022 Facility of the Year Awards (FOYA). In the Supply Chain category, Takeda was awarded for its implementation of a new patient-focused supply chain for its allogeneic mesenchymal stem cell therapy; and Takeda’s vaccine production facility in Sing

Advertisement
Advertisement